IP Verse

Vlassak patent opposition analysis

The comprehensive analysis of Vlassak opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Vlassak

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP2625201	Cd33 Binding Agents	BOEHRINGER INGELHEIM	Jun 7, 2017	ABLYNX
EP2196220	Remedy For Graft-Versus-Host Disease Comprising Interleukin-6 Receptor Inhibitor As The Active Ingredient	CHUGAI SEIYAKU KABUSHIKI KAISHA	Sep 3, 2015	ABLYNX

Top companies who are the clients of Vlassak

Company	Total
ABLYNX	2